Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Core study data such as the title, condition, objectives, eligibility criteria, and outcome measures appear unchanged; observed differences are limited to layout adjustments and minor wording edits. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:44:00.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    3%
    Check dated 2025-10-06T04:24:27.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0. No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:42:47.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed; no other core content or pricing changes were detected.
    Difference
    0.2%
    Check dated 2025-09-14T09:59:14.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T07:56:52.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as various chemical and analytical terms. Notably, the deletion of specific medical topics and compounds suggests a shift in focus or content strategy.
    Difference
    3%
    Check dated 2025-08-31T01:06:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.